Covered recipient · General Payments record
THOMAS S BELLAVIA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,348.83
- Reported across 150 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $146.22 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $19.95 | 1 |
| Lilly USA, LLC | $18.25 | 1 |
| GlaxoSmithKline, LLC. | $16.78 | 1 |
| Amgen Inc. | $16.65 | 1 |
| Acerta Pharma LLC | $15.83 | 1 |
| OWP Pharmaceuticals, Inc. | $15.31 | 1 |
| Collegium Pharmaceutical, Inc. | $15.28 | 1 |
| PFIZER INC. | $14.70 | 1 |
| DEXCOM, INC. | $13.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.95 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125239065 | CMS |
| Amgen Inc. | $16.65 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117504790 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.83 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105639752 | CMS |
| Collegium Pharmaceutical, Inc. | $15.28 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135310797 | CMS |
| Dexcom, Inc. | $13.47 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153340433 | CMS |
| GlaxoSmithKline, LLC. | $16.78 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115984823 | CMS |
| Lilly USA, LLC | $18.25 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135438244 | CMS |
| OWP Pharmaceuticals, Inc. | $15.31 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150025452 | CMS |
| PFIZER INC. | $14.70 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130997028 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.